The Cannabist Company Holdings Inc. (CBST.NE)
| Previous Close | 0.2550 |
| Open | 0.2600 |
| Bid | 0.2350 x N/A |
| Ask | 0.2450 x N/A |
| Day's Range | 0.2250 - 0.2650 |
| 52 Week Range | 0.2250 - 2.0600 |
| Volume | |
| Avg. Volume | 728,713 |
| Market Cap | 116.343M |
| Beta (5Y Monthly) | 1.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
The Cannabist Company Holdings Inc. (PNK:CBSTF) Q1 2024 Earnings Call Transcript
The Cannabist Company Holdings Inc. (PNK:CBSTF) Q1 2024 Earnings Call Transcript May 9, 2024 The Cannabist Company Holdings Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.05. The Cannabist Company Holdings Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see […]
- Insider Monkey
The Cannabist Company Holdings Inc. (PNK:CBSTF) Q4 2023 Earnings Call Transcript
The Cannabist Company Holdings Inc. (PNK:CBSTF) Q4 2023 Earnings Call Transcript March 13, 2024 The Cannabist Company Holdings Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.06. The Cannabist Company Holdings Inc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see […]
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector • The Cannabist Company celebrated approval for adult-use cannabis sales in New York. • Curaleaf gained conditional approval for uplisting to the Toronto Stock Exchange. • MedMen prevailed in legal battle against Whitestar Solutions allegations. Key Takeaways; Psychedelic Sector • Awakn received regulatory and ethical approval for Phase III clinical trial […]
